Skip to content
Review

Electrochemical Biosensors for Circulating Tumor Cells and ctDNA: Emerging Strategies for Precision Oncology.

Sep 2026 · Annals of Biomedical Engineering · 0 citations · 222 references
Medicine

TL;DR

This work highlights strategies specifically designed for epithelial-mesenchymal transition (EMT)-associated CTC phenotypes and explores AI- and IoT-enabled implementations for decentralized oncology, and a comprehensive evaluation of electrochemical approaches for CTC and ctDNA detection.

View source

Similar papers

Review Sep 2026

Translational optical and electrochemical biosensing strategies for liquid biopsy in triple-negative breast Cancer: advances, challenges, and clinical implementation.

This review systematically correlates TNBC biomarkers with optimal sensing technologies, emphasizing how biomolecular properties affect sensor selection and performance and emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically...

Karim G. Mohammed, M. Abdelgawad, Mohamed S. Attia · 0 citations
Review Aug 2026

RNA biosensors in oncology: Mechanisms, Cancer-specific applications, and a Hallmark-aligned clinical roadmap.

Key RNA biosensor classes developed for oncology are examined, spanning fluorescence based platforms such as aptamers, FRET probes, and molecular beacons, enzymatic and electrochemical architectures including CRISPR Cas systems and field effect transistors, metabolite responsive designs encompassing riboswitches, RNA t...

A. Gamage, H. Herath, K. D. de Silva et al. · 0 citations
Review Sep 2026

Microfluidics and biosensors-driven detection of exosomes: advances in aptamers, peptides and POC devices for next-generation diagnostics

This review discusses current breakthroughs in aptamer and peptide functionalized microfluidic biosensors for exosome-based cancer diagnostics, focusing on their translation into POC applications, and highlights present challenges, as well as potential future prospects.

P. Priyanka, S. Hemalatha · 0 citations
Review Open access Aug 2026

Recent advances in biosensors for cancer diagnosis and analytical strategies

This review summarizes relevant biosensor types, including electrochemical, optical, mass-sensitive, microfluidic, nano-biosensors (recently developed), and hydrogel-based systems with discussion of their underlying analytical principles and performance for clinically important cancer biomarkers.

Shruti Patil, Hemant Kumar Tatapudi, Kishore Raju Vatsavai et al. · 0 citations
Review Open access Aug 2026

Label-Free Electrochemical Biosensors for Triple-Negative Breast Cancer Biomarkers: Emerging Recognition Strategies, Nanomaterials, and Clinical Translation

Triple-negative breast cancer (TNBC) is when the patient does not have the three most targeted molecules (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 or HER2) and the patient resorts to chemotherapy (cytotoxic), and poor prognosis due to the fact that the three most targeted m...

T. L. Manasa, R. Upadhyay, H. B. Divyashree · 0 citations
Open access Sep 2026

Fluorosphere-Assisted Nano-Biosensor for Detection of Circulating microRNAs in Non-Small Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) diagnosis is challenged owing to the need for reliable, non-invasive biomarkers. Circulating cell-free microRNAs (ccf-miRNAs) are promising candidates, but their low levels and short sequences in blood complicate detection. In this study, a novel nano-hybrid fluorescent array was deve...

P. K. Mishra, R. Shandilya, Arpit Bhargava et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.